{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T18:17:53Z","timestamp":1778177873626,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T00:00:00Z","timestamp":1730851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T00:00:00Z","timestamp":1730851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"DOI":"10.1007\/s10143-024-03054-z","type":"journal-article","created":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T10:13:10Z","timestamp":1730887990000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Valproate-induced hyperammonemic encephalopathy in neurosurgical patients: Our experience and systematic literature review"],"prefix":"10.1007","volume":"47","author":[{"given":"Sivaraman","family":"Kumarasamy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noufal","family":"Basheer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amol","family":"Raheja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivek","family":"Tandon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajinder","family":"Kumar Laythalling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shashank Sharad","family":"Kale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,6]]},"reference":[{"issue":"4","key":"3054_CR1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.1535-7511.2007.00185.x","volume":"7","author":"LJ Hirsch","year":"2007","unstructured":"Hirsch LJ (2007) The status of intravenous valproate for status. Epilepsy Currents 7(4):96\u201398","journal-title":"Epilepsy Currents"},{"issue":"2","key":"3054_CR2","doi-asserted-by":"publisher","first-page":"s1","DOI":"10.7861\/clinmedicine.18-2-s1","volume":"18","author":"RH Thomas","year":"2018","unstructured":"Thomas RH (2018) Valproate: life-saving, life-changing. Clin Med 18(2):s1\u2013s8","journal-title":"Clin Med"},{"issue":"3","key":"3054_CR3","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.genhosppsych.2011.12.009","volume":"34","author":"A Chopra","year":"2012","unstructured":"Chopra A, Kolla BP, Mansukhani MP, Netzel P, Frye MA (2012) Valproate-induced hyperammonemic encephalopathy: an update on risk factors, clinical correlates and management. Gen Hosp Psychiatry 34(3):290\u2013298","journal-title":"Gen Hosp Psychiatry"},{"key":"3054_CR4","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1023\/A:1021918104127","volume":"17","author":"A Verrotti","year":"2002","unstructured":"Verrotti A, Trotta D, Morgese G, Chiarelli F (2002) Valproate-induced hyperammonemic encephalopathy. Metab Brain Dis 17:367\u2013373","journal-title":"Metab Brain Dis"},{"issue":"154","key":"3054_CR5","first-page":"593","volume":"7","author":"AC Sewell","year":"1995","unstructured":"Sewell AC, Bhles H-J, Herwig J, Demirkol M (1995) Neurological deterioration in patients with urea cycle disorders under valproate therapy a cause for concern. Eur J Pediatr 7(154):593\u2013594","journal-title":"Eur J Pediatr"},{"issue":"3","key":"3054_CR6","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.yebeh.2007.11.004","volume":"12","author":"J Nicolai","year":"2008","unstructured":"Nicolai J, Carr RB (2008) The measurement of ammonia blood levels in patients taking valproic acid: Looking for problems where they do not exist? Epilepsy Behav 12(3):494\u2013496","journal-title":"Epilepsy Behav"},{"issue":"10","key":"3054_CR7","doi-asserted-by":"publisher","first-page":"695","DOI":"10.2165\/00023210-200216100-00004","volume":"16","author":"E Perucca","year":"2002","unstructured":"Perucca E (2002) Pharmacological and therapeutic properties of valproate. CNS Drugs 16(10):695\u2013714","journal-title":"CNS Drugs"},{"issue":"10","key":"3054_CR8","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/j.1553-2712.2001.tb01102.x","volume":"8","author":"F Barrueto","year":"2001","unstructured":"Barrueto F, Hack JB (2001) Hyperammonemia and coma without hepatic dysfunction induced by valproate therapy. Acad Emerg Med 8(10):999\u20131001","journal-title":"Acad Emerg Med"},{"key":"3054_CR9","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00467-011-1838-5","volume":"27","author":"A Auron","year":"2012","unstructured":"Auron A, Brophy PD (2012) Hyperammonemia in review: pathophysiology, diagnosis, and treatment. Pediatr Nephrol 27:207\u2013222","journal-title":"Pediatr Nephrol"},{"key":"3054_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/cc3051","volume":"9","author":"PE Lheureux","year":"2005","unstructured":"Lheureux PE, Penaloza A, Zahir S, Gris M (2005) Science review: carnitine in the treatment of valproic acid-induced toxicity\u2013what is the evidence? Crit Care 9:1\u201310","journal-title":"Crit Care"},{"issue":"2","key":"3054_CR11","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.jhep.2010.11.031","volume":"55","author":"CC Aires","year":"2011","unstructured":"Aires CC, van Cruchten A, Ijlst L, de Almeida IT, Duran M, Wanders RJ et al (2011) New insights on the mechanisms of valproate-induced hyperammonemia: inhibition of hepatic N-acetylglutamate synthase activity by valproyl-CoA. J Hepatol 55(2):426\u201334","journal-title":"J Hepatol"},{"issue":"3","key":"3054_CR12","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.yebeh.2007.06.015","volume":"11","author":"AV Chicharro","year":"2007","unstructured":"Chicharro AV, de Marinis AJ, Kanner AM (2007) The measurement of ammonia blood levels in patients taking valproic acid: looking for problems where they do not exist? Epilepsy Behav 11(3):361\u2013366","journal-title":"Epilepsy Behav"},{"issue":"5","key":"3054_CR13","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/01.jcp.0000138768.61600.ad","volume":"24","author":"M McCall","year":"2004","unstructured":"McCall M, Bourgeois JA (2004) Valproic acid-induced hyperammonemia: a case report. J Clin Psychopharmacol 24(5):521\u2013526","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"3054_CR14","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.jocn.2013.04.033","volume":"21","author":"A Rigamonti","year":"2014","unstructured":"Rigamonti A, Lauria G, Grimod G, Bianchi G, Salmaggi A (2014) Valproate induced hyperammonemic encephalopathy successfully treated with levocarnitine. J Clin Neurosci 21(4):690\u2013691","journal-title":"J Clin Neurosci"},{"issue":"7","key":"3054_CR15","doi-asserted-by":"publisher","first-page":"461","DOI":"10.4103\/0972-5229.136076","volume":"18","author":"A Kumar","year":"2014","unstructured":"Kumar A, Suri A, Sharma BS (2014) Severe valproate induced hyperammonemic encephalopathy successfully managed with peritoneal dialysis. Indian J Crit Care Med: Peer-Reviewed, Official Publ Indian Soc Crit Care Med 18(7):461","journal-title":"Indian J Crit Care Med: Peer-Reviewed, Official Publ Indian Soc Crit Care Med"},{"issue":"2","key":"3054_CR16","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3340\/jkns.2015.58.2.159","volume":"58","author":"S Lee","year":"2015","unstructured":"Lee S, Cheong J, Kim C, Kim JM (2015) Valproic acid-induced hyperammonemic encephalopathy as a cause of neurologic deterioration after unruptured aneurysm surgery. J Korean Neurosurg Soc 58(2):159\u2013162","journal-title":"J Korean Neurosurg Soc"},{"issue":"15","key":"3054_CR17","doi-asserted-by":"publisher","first-page":"e6588","DOI":"10.1097\/MD.0000000000006588","volume":"96","author":"X Guo","year":"2017","unstructured":"Guo X, Wei J, Gao L, Xing B, Xu Z (2017) Hyperammonemic coma after craniotomy: hepatic encephalopathy from upper gastrointestinal hemorrhage or valproate side effect?: case report and literature review. Medicine 96(15):e6588","journal-title":"Medicine"},{"key":"3054_CR18","doi-asserted-by":"crossref","unstructured":"Mithani F, Cullum S, Chacko R (2020) Valproic acid rechallenge after valproate-induced hyperammonemic encephalopathy. In: Baylor University Medical Center Proceedings. Taylor & Francis.\u00a033(3):471\u2013472","DOI":"10.1080\/08998280.2020.1767460"},{"key":"3054_CR19","first-page":"197","volume":"34","author":"V Fuellis","year":"2022","unstructured":"Fuellis V, Grille P, Verga F, Alfaro LU, Grasiuso L, Barbato M (2022) Valproate-associated hyperammonemic encephalopathy in subarachnoid hemorrhage: a diagnosis to consider. Revista Brasileira de Terapia Intensiva 34:197\u2013201","journal-title":"Revista Brasileira de Terapia Intensiva"},{"key":"3054_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13256-020-2343-x","volume":"14","author":"S Shah","year":"2020","unstructured":"Shah S, Wang R, Vieux U (2020) Valproate-induced hyperammonemic encephalopathy: a case report. J Med Case Reports 14:1\u20134","journal-title":"J Med Case Reports"},{"issue":"9","key":"3054_CR21","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1001\/archneur.1982.00510210061016","volume":"39","author":"JV Murphy","year":"1982","unstructured":"Murphy JV (1982) Asymptomatic hyperammonemia in patients receiving valproic acid. Arch Neurol 39(9):591\u2013592","journal-title":"Arch Neurol"},{"issue":"6","key":"3054_CR22","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1136\/jnnp.69.6.813","volume":"69","author":"M Bogdanovic","year":"2000","unstructured":"Bogdanovic M, Kidd D, Briddon A, Duncan J, Land J (2000) Late onset heterozygous ornithine transcarbamylase deficiency mimicking complex partial status epilepticus. J Neurol Neurosurg Psychiatry 69(6):813\u2013815","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"3054_CR23","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1056\/NEJM198003203021204","volume":"302","author":"TR Browne","year":"1980","unstructured":"Browne TR (1980) Valproic acid. N Engl J Med 302(12):661\u2013666","journal-title":"N Engl J Med"},{"issue":"5","key":"3054_CR24","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1136\/jnnp.64.5.680","volume":"64","author":"M Oechsner","year":"1998","unstructured":"Oechsner M, Steen C, St\u00fcrenburg H, Kohlsch\u00fctter A (1998) Hyperammonaemic encephalopathy after initiation of valproate therapy in unrecognised ornithine transcarbamylase deficiency. J Neurol Neurosurg Psychiatry 64(5):680\u2013682","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"3054_CR25","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1046\/j.1528-1157.2002.42401.x","volume":"43","author":"E Longin","year":"2002","unstructured":"Longin E, Teich M, Koelfen W, K\u00f6nig S (2002) Topiramate enhances the risk of valproate-associated side effects in three children. Epilepsia 43(4):451\u2013454","journal-title":"Epilepsia"},{"issue":"6","key":"3054_CR26","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1002\/hep.1840040609","volume":"4","author":"JW Kesterson","year":"1984","unstructured":"Kesterson JW, Granneman GR, Machinist JM (1984) The hepatotoxicity of valproic acid and its metabolites in rats. I. Toxicologic, biochemical and histopathologic studies. Hepatology 4(6):1143\u201352","journal-title":"Hepatology"},{"issue":"3","key":"3054_CR27","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1212\/WNL.38.3.365","volume":"38","author":"AM Marini","year":"1988","unstructured":"Marini AM, Zaret BS, Beckner RR (1988) Hepatic and renal contributions to valproic acid-induced hyperammonemia. Neurology 38(3):365","journal-title":"Neurology"},{"issue":"7","key":"3054_CR28","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1177\/088307389701200709","volume":"12","author":"S Altunbsak","year":"1997","unstructured":"Altunbsak S, Baytok V, Tasouji M, Herg\u00fcner \u00d6, Burgut R, Kayrin L (1997) Asymptomatic hyperammonemia in children treated with valproic acid. J Child Neurol 12(7):461\u2013463","journal-title":"J Child Neurol"},{"issue":"1","key":"3054_CR29","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1528-1157.1994.tb02928.x","volume":"35","author":"JR Stephens","year":"1994","unstructured":"Stephens JR, Levy RH (1994) Effects of valproate and citrulline on ammonium-induced encephalopathy. Epilepsia 35(1):164\u2013171","journal-title":"Epilepsia"},{"key":"3054_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2193-1801-2-13","volume":"2","author":"C Sousa","year":"2013","unstructured":"Sousa C (2013) Valproic acid-induced hyperammonemic encephalopathy\u2013a potentially fatal adverse drug reaction. Springerplus 2:1\u20133","journal-title":"Springerplus"},{"issue":"3","key":"3054_CR31","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1528-1157.1990.tb05387.x","volume":"31","author":"E Beghi","year":"1990","unstructured":"Beghi E, Bizzi A, Codegoni AM, Trevisan D, Torri W (1990) Valproate, carnitine metabolism, and biochemical indicators of liver function. Epilepsia 31(3):346\u2013352","journal-title":"Epilepsia"},{"issue":"5","key":"3054_CR32","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1345\/aph.19242","volume":"34","author":"JY Raskind","year":"2000","unstructured":"Raskind JY, El-Chaar GM (2000) The role of carnitine supplementation during valproic acid therapy. Ann Pharmacother 34(5):630\u2013638","journal-title":"Ann Pharmacother"},{"key":"3054_CR33","doi-asserted-by":"publisher","first-page":"e597","DOI":"10.1016\/j.wneu.2020.09.027","volume":"144","author":"PY Woo","year":"2020","unstructured":"Woo PY, Woo AW, Lam SW, Ko NM, Ho JW, Chu AC et al (2020) Incidence, presentation, and risk factors for sodium valproate-associated hyperammonemia in neurosurgical patients: a prospective: Observational Study. World Neurosurg 144:e597\u2013e604","journal-title":"World Neurosurg"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-024-03054-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10143-024-03054-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-024-03054-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T10:36:48Z","timestamp":1741084608000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10143-024-03054-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,6]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3054"],"URL":"https:\/\/doi.org\/10.1007\/s10143-024-03054-z","relation":{},"ISSN":["1437-2320"],"issn-type":[{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,6]]},"assertion":[{"value":"16 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Consent to participate and consent for publication was taken from the patient using written informed consent to publish from the parent. Ethics committee approval was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"836"}}